Physician

Reena Natvarlal Patel

According to 2025 Medicare claims, Reena Patel (NPI: 1346288149) practices ophthalmology in the Wichita, KS market, with the plurality of this provider's patient population coming from Sedgwick, KS. This provider's primary affiliated billing organization is WICHITA VISION INSTITUTE P.A. (NPI: 1811932353) and primary practice location at 67205-7343. Patel is affiliated with the Aledade 155 National MSSP (ACO ID: A5358), participating under the MSSP model.

Patel's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 951 traditional Medicare patients, billed 19,869 HCPCS/CPT codes, and received $899,907 in Medicare payments. The top billing code was 68761 (Closure of tear duct opening using plug). Part D data shows 3,084 prescription claims across 656 beneficiaries totaling $689,475 in drug costs, led by Restasis (Cyclosporine). Open Payments data shows 23 records totaling $1,133. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $375,394 to $899,907. Similarly, Part D prescription costs have risen steadily, from $138,457 to $689,475. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$450K$900K2015 Medicare payment: $375,394 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $476,267 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $519,083 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $564,202 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $677,514 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $693,789 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $819,571 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $821,665 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $762,956 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $899,907 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20157506,139$375,394
20168568,737$476,267
201787610,293$519,083
201891011,578$564,202
201993912,504$677,514
202088912,682$693,789
202194816,359$819,571
202297617,176$821,665
202393016,946$762,956
202495119,869$899,907

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$918K$1.8M2015 Drug cost: $138,457 (USD; Tot_Drug_Cst)2016 Drug cost: $192,589 (USD; Tot_Drug_Cst)2017 Drug cost: $215,089 (USD; Tot_Drug_Cst)2018 Drug cost: $233,092 (USD; Tot_Drug_Cst)2019 Drug cost: $1,836,759 (USD; Tot_Drug_Cst)2020 Drug cost: $259,724 (USD; Tot_Drug_Cst)2021 Drug cost: $362,606 (USD; Tot_Drug_Cst)2022 Drug cost: $703,405 (USD; Tot_Drug_Cst)2023 Drug cost: $1,007,928 (USD; Tot_Drug_Cst)2024 Drug cost: $689,475 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015293969$138,457
20163461,584$192,589
20173621,524$215,089
20183321,377$233,092
20194121,750$1,836,759
20204061,506$259,724
20215322,039$362,606
20225822,434$703,405
20235942,513$1,007,928
20246563,084$689,475

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
68761Closure of tear duct opening using plug8353,202$70
92025Ct scan of cornea8021,607$22
92250Photography of the retina7951,036$22
83861Microfluid analysis of tears8844,156$22
92285Photography of content of eyes9052,340$14

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
RestasisCyclosporine28911,777$217,861
MieboPerfluorohexyloctane/Pf2417,010$179,547
XiidraLifitegrast883,480$79,629
TyrvayaVarenicline Tartrate321,125$24,649
CequaCyclosporine301,260$23,967

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.23$1,133Glaukos Corporation
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Reena Natvarlal Patel?

Tedicare shows public-source Medicare data for Reena Natvarlal Patel (NPI 1346288149), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Reena Natvarlal Patel have ACO affiliation data?

Reena Natvarlal Patel is shown with ACO affiliation data for Aledade 155 National MSSP (MSSP, ACO ID A5358).

What billing organization is linked to Reena Natvarlal Patel?

Reena Natvarlal Patel is linked to WICHITA VISION INSTITUTE P.A. (billing NPI 1811932353) in the available physician profile data.

Does Reena Natvarlal Patel have Open Payments data?

Reena Natvarlal Patel has 23 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.